CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 260 filers reported holding CONMED CORP in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,993,000 | -22.7% | 743,613 | +4.1% | 0.09% | -15.3% |
Q2 2023 | $97,064,000 | +22.5% | 714,280 | -6.4% | 0.11% | +18.1% |
Q1 2023 | $79,239,000 | +20.0% | 762,937 | +2.4% | 0.09% | +20.5% |
Q4 2022 | $66,034,000 | +12.2% | 744,969 | +1.5% | 0.08% | +8.3% |
Q3 2022 | $58,872,000 | -14.6% | 734,010 | +1.9% | 0.07% | -6.5% |
Q2 2022 | $68,971,000 | -34.2% | 720,246 | +2.0% | 0.08% | -3.8% |
Q1 2022 | $104,854,000 | -2.6% | 705,854 | -7.1% | 0.08% | -11.1% |
Q4 2021 | $107,657,000 | +5.4% | 759,433 | -2.7% | 0.09% | +3.4% |
Q3 2021 | $102,093,000 | -3.6% | 780,350 | +1.2% | 0.09% | 0.0% |
Q2 2021 | $105,945,000 | +10.5% | 770,902 | +5.0% | 0.09% | -36.0% |
Q1 2021 | $95,914,000 | +10.4% | 734,466 | -5.3% | 0.14% | +7.1% |
Q4 2020 | $86,880,000 | +47.2% | 775,717 | +3.4% | 0.13% | +27.0% |
Q3 2020 | $59,010,000 | +10.8% | 750,096 | +1.3% | 0.10% | +8.7% |
Q2 2020 | $53,282,000 | +24.9% | 740,129 | -0.6% | 0.09% | +4.5% |
Q1 2020 | $42,663,000 | -48.9% | 744,944 | -0.2% | 0.09% | -26.1% |
Q4 2019 | $83,484,000 | +20.6% | 746,532 | +3.7% | 0.12% | +2.6% |
Q3 2019 | $69,234,000 | -66.0% | 720,059 | -69.8% | 0.12% | 0.0% |
Q2 2019 | $203,709,000 | +205.0% | 2,380,593 | +196.5% | 0.12% | +1.8% |
Q1 2019 | $66,794,000 | +28.9% | 802,995 | -0.5% | 0.11% | +14.0% |
Q4 2018 | $51,819,000 | -17.3% | 807,148 | +2.1% | 0.10% | -2.0% |
Q3 2018 | $62,643,000 | +9.8% | 790,740 | +1.4% | 0.10% | +4.1% |
Q2 2018 | $57,055,000 | +13.2% | 779,440 | -2.1% | 0.10% | +6.5% |
Q1 2018 | $50,397,000 | +30.8% | 795,781 | +5.3% | 0.09% | +35.3% |
Q4 2017 | $38,519,000 | +0.3% | 755,724 | +3.2% | 0.07% | -1.4% |
Q3 2017 | $38,406,000 | +17.3% | 731,957 | +13.9% | 0.07% | +15.0% |
Q2 2017 | $32,748,000 | +9.3% | 642,879 | -4.7% | 0.06% | +11.1% |
Q1 2017 | $29,961,000 | +16.2% | 674,656 | +15.5% | 0.05% | +10.2% |
Q4 2016 | $25,794,000 | +14.2% | 583,971 | +3.6% | 0.05% | +14.0% |
Q3 2016 | $22,581,000 | -55.9% | 563,672 | -47.4% | 0.04% | -14.0% |
Q2 2016 | $51,156,000 | +179.2% | 1,071,760 | +145.3% | 0.05% | +35.1% |
Q1 2016 | $18,321,000 | +12.9% | 436,840 | +18.6% | 0.04% | +12.1% |
Q4 2015 | $16,222,000 | +0.1% | 368,264 | +8.4% | 0.03% | -5.7% |
Q3 2015 | $16,212,000 | -0.2% | 339,597 | +21.8% | 0.04% | +9.4% |
Q2 2015 | $16,250,000 | +6.5% | 278,882 | -7.7% | 0.03% | +6.7% |
Q1 2015 | $15,254,000 | +62.6% | 302,126 | +44.8% | 0.03% | +57.9% |
Q4 2014 | $9,384,000 | +59.2% | 208,712 | +30.4% | 0.02% | +46.2% |
Q3 2014 | $5,896,000 | +6.9% | 160,056 | +28.1% | 0.01% | +8.3% |
Q2 2014 | $5,516,000 | +15.0% | 124,949 | +13.2% | 0.01% | +50.0% |
Q1 2014 | $4,796,000 | +38.6% | 110,384 | +35.6% | 0.01% | +33.3% |
Q4 2013 | $3,461,000 | +38.1% | 81,425 | +10.4% | 0.01% | +20.0% |
Q3 2013 | $2,507,000 | +4.9% | 73,785 | -3.5% | 0.01% | 0.0% |
Q2 2013 | $2,390,000 | – | 76,490 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |